艾尔瓦·拉纳塔对骨髓瘤细胞系通过亡信号通路的瘤效应
Ummu Zuvairiya1, Menaka S1, Selvaraj Jayaraman2
1Department of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.
Cureus
|May 13, 2024
概括
Aerva lanata 提取物对骨髓瘤细胞表现出抗癌作用. 它通过减少B细胞淋巴瘤2 (Bcl2) 标记物和增加p53瘤抑制蛋白来诱导细胞死亡.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 骨髓瘤带来了重大的治疗挑战,推动了寻找替代治疗方法的研究.
- 阿尔瓦·拉纳塔 (Aerva lanata) 是一种药用植物,具有已记录的抗癌性质.
- 研究天然化合物为新型骨髓瘤治疗提供了潜力.
研究的目的:
- 为了评估Aerva lanata提取物在骨髓瘤细胞系上的瘤治疗潜力.
- 阐明了在提取物抗癌机制中的亡信号通路的作用.
- 确定Aerva lanata对Saos2细胞中关键的亡相关基因的影响.
主要方法:
- 索克斯莱特提取物被用来制备Aerva lanata提取物.
- 用MTT测定对Saos2骨髓瘤细胞进行细胞毒性评估.
- 进行基因表达分析 (RT-PCR) 来研究亡标志物 (Bcl2,p53).
主要成果:
- Aerva lanata 提取物表现出对Saos2细胞增殖 (50-200μg) 的剂量依赖抑制.
- 提取物显著降低了抗亡基因B细胞淋巴瘤2 (Bcl2) 的mRNA水平.
- 相反,提取物上调了瘤抑制基因p53.3的mRNA水平.
结论:
- Aerva lanata 提取物对骨髓瘤细胞具有显著的抗癌活性.
- 提取物通过调节Bcl2和p53表达来诱导Saos2细胞的亡.
- 阿尔瓦·拉纳塔 (Aerva lanata) 是一个有希望的天然治疗候选人,用于骨髓瘤治疗.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


